CHIR 99021 CAS 252917-06-9
| CAS No. | 252917-06-9 |
| Molecular Formula | C22H18Cl2N8 |
| Molecular Weight | 465.34 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CHIR 99021 (C22H18Cl2N8) contains a nitrogen-containing heterocyclic scaffold, a nitrile group, chlorine substitution. Halogen substitution raises its density and boiling point; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
CHIR 99021 (CAS 252917-06-9), molecular formula C22H18Cl2N8 and molecular weight 465.34 g/mol, is a CATO reference standard with documented purity and traceability.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C22H18Cl2N8 |
| Molecular Weight | 465.34 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 17.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 8 |
Related CHIR Standards
Recommended Standards
- 3-Bromo-4-ethoxy-N-(2-methyl-5-(6-methylbenzo[d]oxazol-2-yl)phenyl)benzamide (CAS 590397-47-0)
- O-Demethyl Vandetanib-d4 (CAS 1346599-97-0)
- 2-(4-Bromo-2-((4-oxo-3-(pyridin-3-ylmethyl)-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)acetic acid (CAS 432001-69-9)
- N-Demethyl Vandetanib-d4 (CAS 1346603-93-7)
- 4-Hydroxypiperidine-2-carboxylic acid hydrochloride (CAS 89531-61-3)
- 2-Chloro-4-(trichloromethyl)pyridine (CAS 52413-82-8)
- Dimethyl 5-(4-methoxyphenyl)-1H,3H-pyrrolo[1,2-c]thiazole-6,7-dicarboxylate 2,2-dioxide (CAS 339113-76-7)
- 3,6-Dimethylheptanoic acid (CAS 44980-98-5)
- 1-methyl-1H-pyrrolo[3,2-b]pyridin-5-amine (CAS 947688-70-2)
- Tris(3-aminophenyl)phosphine oxide (CAS 36357-49-0)
- 5-((((5-Methylfuran-2-yl)methyl)amino)methyl)pyrrolidin-2-one (CAS 1342958-43-3)
- (S)-tert-butyl 5-(1-aminoethyl)-1h-pyrrolo[3,2-b]pyridine-1-carboxylate (CAS 1962081-46-4)
- 6-(difluoromethoxy)-2H-1,3-benzodioxole-5-carbaldehyde (CAS 1250313-60-0)
- Hexapeptide-11 (CAS 100684-36-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com